Showing 1 - 7 results of 7 for search 'XiaoJun Wu', query time: 0.03s Refine Results
  1. 1
    An Improved AAM Method for Extracting Human Facial Features

    An Improved AAM Method for Extracting Human Facial Features by Tao Zhou, Xiao-Jun Wu, Tao Wu, Zhen-Hua Feng

    Published 2012-01-01
    Get full text
    Article
  2. 2
    Face Recognition via Compact Second-Order Image Gradient Orientations

    Face Recognition via Compact Second-Order Image Gradient Orientations by He-Feng Yin, Xiao-Jun Wu, Cong Hu, Xiaoning Song

    Published 2022-07-01
    Get full text
    Article
  3. 3
    Deep Grassmannian multiview subspace clustering with contrastive learning

    Deep Grassmannian multiview subspace clustering with contrastive learning by Rui Wang, Haiqiang Li, Chen Hu, Xiao-Jun Wu, Yingfang Bao

    Published 2024-09-01
    Get full text
    Article
  4. 4
    Tidal Disruptions of Stars by Supermassive and Intermediate-mass Black Hole Binaries: The Effects of the First-order Post-Newtonian Cross Terms

    Tidal Disruptions of Stars by Supermassive and Intermediate-mass Black Hole Binaries: The Effects of the First-order Post-Newtonian Cross Terms by Xiao-Jun Wu, Yan Luo, Jie Li, Ye-Fei Yuan, Wenbin Lin

    Published 2025-01-01
    Get full text
    Article
  5. 5
    Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for initially unresectable locally advanced colon cancer: short-term outcomes of an open-label, single-centre, randomised, controlled, phase 3 trialResearch in context

    Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for initially unresectable locally advanced colon cancer: short-term outcomes of an open-label, single-centre, randomi... by Zi-Tong Zhang, Wei-Wei Xiao, Li-Ren Li, Xiao-Jun Wu, Qiao-Xuan Wang, Hui Chang, Xue Tian, Wu Jiang, Jun-Zhong Lin, Rong-Xin Zhang, Wen-Hua Fan, Zhi-Zhong Pan, Rong Zhang, Yuan-Hong Gao

    Published 2024-10-01
    Get full text
    Article
  6. 6
    Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial

    Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A... by De-Shen Wang, Chao Ren, Shan-Shan Li, William Pat Fong, Xiao-Jun Wu, Jian Xiao, Bin-Kui Li, Yun Zheng, Pei-Rong Ding, Gong Chen, Miao-Zhen Qiu, Zhi-Qiang Wang, Feng-Hua Wang, Hui-Yan Luo, Feng Wang, Xiao-Zhong Wang, Ling-Yun Wang, De-Jin Xie, Tao Chen, Li-Ren Li, Zhen-Hai Lu, Xiao-Hui Zhai, Tian-Shu Liu, Ying Yuan, Jia-Qi Chen, Qiong Tan, Zhi-Zhong Pan, De-Sen Wan, Rong Zhang, Yun-Fei Yuan, Rui-Hua Xu, Yu-Hong Li

    Published 2024-05-01
    Get full text
    Article
  7. 7
    Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial.

    Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A... by De-Shen Wang, Chao Ren, Shan-Shan Li, William Pat Fong, Xiao-Jun Wu, Jian Xiao, Bin-Kui Li, Yun Zheng, Pei-Rong Ding, Gong Chen, Miao-Zhen Qiu, Zhi-Qiang Wang, Feng-Hua Wang, Hui-Yan Luo, Feng Wang, Xiao-Zhong Wang, Ling-Yun Wang, De-Jin Xie, Tao Chen, Li-Ren Li, Zhen-Hai Lu, Xiao-Hui Zhai, Tian-Shu Liu, Ying Yuan, Jia-Qi Chen, Qiong Tan, Zhi-Zhong Pan, De-Sen Wan, Rong Zhang, Yun-Fei Yuan, Rui-Hua Xu, Yu-Hong Li

    Published 2024-05-01
    Get full text
    Article

Search Tools: